Vertex Pharmaceuticals Incorporated VRTX
$455.82▼ -0.02% 24H
Super Investor & Insider
1
Fondi che lo detengono
#952
Rank consenso
1.4%
% dei portafogli
$18.0M
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Tweedy Browne · Tweedy Browne | 1.43% | Add 3.16% | 40,387 | $18.0M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Vertex Pharmaceuticals Incorporated is a global biopharmaceutical company headquartered in Boston, Massachusetts, specializing in the discovery, development, and commercialization of transformative medicines for patients with serious diseases. The company's primary focus centers on cystic fibrosis, where it has develop…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees6,400
TickerVRTX
Statistics
Market Cap$115.85B
Revenue (TTM)$12.00B
Net Income$3.95B
Net Margin32.9%
EPS$15.32
P/E26.40
P/S9.24
P/B5.84
EV/EBITDA21.14
ROE24.2%
Dividend Yield—
Price$455.82
Data: Twelve Data · Revenue = mcap / P/S